CHEK1 and head and neck squamous cell carcinoma: We also validated the effectiveness of the inhibitors in supressing kinase activity in HNSCC cell lines following X-ray irradiation, by analysing the phosphorylation of either the auto-phosphorylation site on Chk1 (pS296) or the downstream target of CDC2 (pY15).